Closed consultation

Reclassify Soleve Sunburn Relief cutaneous emulsion

• From: Medicines and Healthcare products Regulatory Agency
• Published: 14 January 2015

We are analysing your feedback

Visit this page again soon to download the outcome to this public feedback.

Summary

MHRA is asking for feedback on proposals to reclassify Soleve Sunburn Relief Cutaneous Emulsion from pharmacy to general sales list.

This consultation ran from
14 January 2015 to 11:45pm on 4 February 2015

Consultation description

The Commission on Human Medicines has advised that this product can be available as a general sales list medicine.

Documents

Reclassify Soleve Sunburn Relief cutaneous emulsion

PDF, 1.17 MB, 11 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email webupdates@mhra.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Published 14 January 2015